XIAP Monoclonal Antibody
Applications
Reactivity
| Overview | |
| Catalog # | bsm-51607m-100uL |
| Product Name | XIAP Monoclonal Antibody |
| Applications |
WB
|
| Reactivity | Human |
| Specifications | |
| Conjugation | Unconjugated |
| Host | Mouse |
| Source | Recombinant human XIAP. |
| Clonality | Monoclonal |
| Clone # | D1G6 |
| Isotype | IgG1 κ |
| Concentration | Lot Dependent |
| Purification | Purified by Protein G. |
| Storage Buffer | 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol. |
| Storage Condition | Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. |
| Target | |
| Gene ID | 331 |
| Swiss Prot | P98170 |
| Subcellular location | Cytoplasm |
| Synonyms | X-linked Inhibitor of Apoptosis Protein; RIAP-3; Baculoviral IAP repeat-containing protein 4; E3 ubiquitin-protein ligase XIAP; Inhibitor of apoptosis protein 3; X-linked IAP; IAP-like protein; HILP; BIRC4; HILP; XLP2; ILP1; Xiap; MIHA; hILP; IAP3; API3; XIAP_HUMAN; ILP; hILP; IAP-3; hIAP-3; hIAP3; X-linked inhibitor of apoptosis protein. |
| Background | Apoptotic suppressor. Has E3 ubiquitin-protein ligase activity. Mediates the proteasomal degradation of target proteins, such as caspase-3, SMAC or AIFM1. Inhibitor of caspase-3, -7 and -9. Mediates activation of MAP3K7/TAK1, leading to the activation of NF-kappa-B. |
| Application Dilution | |
| WB | 1:500-5000 |
Frequently asked questions
Which applications is XIAP Monoclonal Antibody (bsm-51607M) validated for, and at what dilution?
bsm-51607M is validated for WB(WB) (1:500-5000). These are recommended starting dilutions; optimal dilutions should be determined by the end user.
Which species does XIAP Monoclonal Antibody (bsm-51607M) react with?
Tested reactivity: Human.
How should bsm-51607M be stored?
Shipped at 4C. Store at -20C for one year. Avoid repeated freeze/thaw cycles. Storage buffer: 0.01M TBS(pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
What immunogen was used to raise XIAP Monoclonal Antibody (bsm-51607M)?
Recombinant human XIAP.